Search
Search Results
##search.searchResults.foundPlural##
-
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1289PDF: 481HTML: 179 -
-
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1468PDF: 730HTML: 2106Untitled: 176Untitled: 172Untitled: 181Untitled: 163Untitled: 179 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2075PDF: 1524HTML: 248 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2371HTML: 252PDF: 822 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1329PDF: 656HTML: 1067Untitled: 165Untitled: 130Untitled: 114Untitled: 137Untitled: 143 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4242PDF: 1449HTML: 1531Untitled: 210 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1541PDF: 1039HTML: 99 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1480PDF: 560HTML: 170 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2683PDF: 1754HTML: 3633Pellagatti Fig 1: 188Pellagatti Fig. 2: 188 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1426PDF: 894HTML: 208 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2079PDF: 1740HTML: 119 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1866PDF: 1053HTML: 567 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2570PDF: 945HTML: 4684 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
624PDF: 482HTML: 199 -
Simultaneous dual pathology in lymph node
1609PDF: 669HTML: 7673Simultaneous dual pathology in lymph node: 159Simultaneous dual pathology in lymph node: 154Simultaneous dual pathology in lymph node: 137Simultaneous dual pathology in lymph node: 169Simultaneous dual pathology in lymph node: 158 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1352PDF: 645HTML: 1364cover letter: 188 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1856PDF: 1125HTML: 248 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4561PDF: 1281HTML: 1887Untitled: 165Untitled: 162 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2254PDF: 939HTML: 7606Untitled: 254Fig2: 163Fig3: 143Fig4: 162 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3955PDF: 1895HTML: 5192Table 1: 166 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3767PDF: 1410HTML: 8486 -
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3500PDF: 834HTML: 6695 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1084PDF: 875HTML: 280 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
1700PDF: 770HTML: 434







